Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment
暂无分享,去创建一个
Bruno Domon | Marc Hirschfeld | Xavier Matias-Guiu | B. Domon | X. Matías-Guiu | M. Hirschfeld | A. Gómez-Tato | E. Colás | J. Reventós | A. Gil-Moreno | J. van Oostrum | Jan van Oostrum | Antoine Lesur | S. Cabrera | Elena Martinez-Garcia | Laura Devis | Silvia Cabrera | Antonio Gil-Moreno | Jaume Reventos | Eva Colas | Antonio Gómez-Tato | M. Á. Casares de Cal | Jasmin Asberger | María de Los Ángeles Casares de Cal | L. Devis | A. Lesur | J. Asberger | Elena Martinez-Garcia
[1] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[2] K. Astrup,et al. Frequency of spontaneously occurring postmenopausal bleeding in the general population , 2004, Acta obstetricia et gynecologica Scandinavica.
[3] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[4] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[5] Ibrahim Anwar Abdelazim,et al. Pipelle endometrial sampling versus conventional dilatation & curettage in patients with abnormal uterine bleeding. , 2013, Journal of the Turkish German Gynecological Association.
[6] S. Shivaji,et al. Proteome of human endometrium: Identification of differentially expressed proteins in proliferative and secretory phase endometrium , 2010, Proteomics. Clinical applications.
[7] Bruno Domon,et al. Advances in high‐resolution accurate mass spectrometry application to targeted proteomics , 2015, Proteomics.
[8] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[9] L. Mattsson,et al. Histopathological findings in women with postmenopausal bleeding , 1995, British journal of obstetrics and gynaecology.
[10] Walter Birchmeier,et al. Balancing cell adhesion and Wnt signaling, the key role of β-catenin , 2006 .
[11] Deanna Telner,et al. Approach to diagnosis and management of abnormal uterine bleeding. , 2007, Canadian family physician Medecin de famille canadien.
[12] T. Colgan,et al. Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer. , 2009, Analytical chemistry.
[13] M. Jiang,et al. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis , 2010, Journal of experimental & clinical cancer research : CR.
[14] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[15] J. Gupta,et al. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review , 2002, BJOG : an international journal of obstetrics and gynaecology.
[16] T. Herzog,et al. Endometrial cancer: a review and current management strategies: part I. , 2014, Gynecologic oncology.
[17] J. Quigley,et al. Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.
[18] J. Lacey,et al. Endometrial hyperplasia and the risk of progression to carcinoma. , 2009, Maturitas.
[19] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[20] E. Noordijk,et al. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. , 2003, The Journal of pathology.
[21] R. Soslow,et al. β-Catenin and E-Cadherin Expression Patterns in High-Grade Endometrial Carcinoma Are Associated with Histological Subtype , 2002, Modern Pathology.
[22] M. C. Terek,et al. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer. , 2016, Gynecologic oncology.
[23] S. Ghanny,et al. Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format. , 2007, Journal of proteome research.
[24] Walter Birchmeier,et al. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. , 2006, Current opinion in genetics & development.
[25] S. Skates,et al. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin. , 2007, Gynecologic oncology.
[26] Jason D. Wright,et al. Comparative Performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for Uterine Corpus Cancer. , 2011, Obstetrics and gynecology.
[27] P. E. Van den Steen,et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade , 2013, Critical reviews in biochemistry and molecular biology.
[28] Patrick Neven,et al. Endometrial cancer. , 2005, Lancet.
[29] Jörg Grigull,et al. Endometrial Carcinoma Biomarker Discovery and Verification Using Differentially Tagged Clinical Samples with Multidimensional Liquid Chromatography and Tandem Mass Spectrometry*S , 2007, Molecular & Cellular Proteomics.
[30] B. Domon,et al. Detection and quantification of proteins in clinical samples using high resolution mass spectrometry. , 2015, Methods.
[31] T. Fehm,et al. Macrophage Capping Protein CapG Is a Putative Oncogene Involved in Migration and Invasiveness in Ovarian Carcinoma , 2014, BioMed research international.
[32] T. Enomoto,et al. Serum Biomarkers for Early Detection of Gynecologic Cancers , 2010, Cancers.
[33] Ian Todd,et al. ELISA in the multiplex era: Potentials and pitfalls , 2015, Proteomics. Clinical applications.
[34] A. García,et al. Molecular pathology of endometrial hyperplasia and carcinoma. , 2001, Human pathology.
[35] Jin-Ju Kim,et al. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women , 2016, Obstetrics & gynecology science.
[36] R. Kimmig,et al. Cellular Apoptosis Susceptibility Gene Expression in Endometrial Carcinoma: Correlation With Bcl-2, Bax, and Caspase-3 Expression and Outcome , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[37] I. Căruntu,et al. Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium. , 2011, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[38] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[39] Gloria S. Huang,et al. Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors. , 2007, American journal of obstetrics and gynecology.
[40] D. Kiresi,et al. Evaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleeding , 2010, Archives of Gynecology and Obstetrics.
[41] S. Nofech-Mozes,et al. Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer , 2010, British Journal of Cancer.
[42] Gerben ter Riet,et al. Endometrial Thickness Measurement for Detecting Endometrial Cancer in Women With Postmenopausal Bleeding: A Systematic Review and Meta-Analysis , 2010, Obstetrics and gynecology.
[43] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[44] J. Quinlivan,et al. Endometrial adenocarcinoma ‐ presenting pathology is a poor guide to surgical management , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.
[45] S. Pecorelli. Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .
[46] R. Bamezai,et al. Pyruvate kinase M2 and cancer: an updated assessment , 2014, FEBS letters.
[47] U. Brinkmann,et al. CSE1L/CAS: Its role in proliferation and apoptosis , 2004, Apoptosis.
[48] Bruno Domon,et al. Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples , 2016, Oncotarget.
[49] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.
[50] C. Creutzberg,et al. Nuclear β‐catenin is a molecular feature of type I endometrial carcinoma , 2003 .
[51] Tom Fawcett,et al. An introduction to ROC analysis , 2006, Pattern Recognit. Lett..
[52] B. Domon,et al. Recent advances in targeted proteomics for clinical applications , 2015, Proteomics. Clinical applications.